drugset / Trial / NCT04609059

First-in-Patient Study for Sing le Dose of M201-A Hydrochloride Injection in Japanese Patients With Paroxysmal Atrial Fibrillation

NCT04609059 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

First-in-Patient Study for sing le dose of M201-A hydrochloride injection in Japanese patients with paroxysmal atrial fibrillation.

Timeline

Start
2019-05-07
Primary completion
2019-10-01
Completion
2020-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject M201-A Unknown 0.2 mg/kg Intravenous
Subject M201-A Unknown 0.4 mg/kg Intravenous
Subject M201-A Unknown 0.6 mg/kg Intravenous